SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000921895-15-002191
Filing Date
2015-10-02
Accepted
2015-10-02 17:15:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422cti_10022015.htm SC 13G 189177
2 JOINT FILING AGREEMENT ex991tosc13g07422cti_100215.htm EX-99.1 27856
  Complete submission text file 0000921895-15-002191.txt   218693
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 151141329
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice